Recent Updates
Recently added Catalysts
NSPR

InspireMD to Ring Opening Bell at New York Stock Exchange on Thursday, October 24th BOSTON, MA

Key Takeaway: InspireMD to Ring Opening Bell at New on Thursday, October 24th BOSTON, MA - October 23, 2013 - InspireMD, Inc. (NYSE MKT: NSPR) ("InspireMD" or the "Company"), a leader in embolic protection stents, announced today that it will ring the Opening Bell at the New York Stock Exc

Full Press Release Details

InspireMD to Ring Opening Bell at New
on Thursday, October 24th
BOSTON, MA - October 23, 2013 -
InspireMD, Inc. (NYSE MKT: NSPR) ("InspireMD" or the "Company"),
a leader in embolic protection stents, announced today that it will ring the Opening Bell at the New York Stock Exchange on Thursday,
October 24, 2013 at 9:30 a.m. ET.
Representing the Company, Alan Milinazzo,
Chief Executive Officer, and Craig Shore, Chief Financial Officer, will be joined by members of the InspireMD management team to
ring the Opening Bell.
"We look forward to ringing the Opening
Bell at the New York Stock Exchange as we celebrate the progress made by the Company over the past year," said Alan Milinazzo,
Chief Executive Officer of InspireMD. "Over the next year, we are looking forward to several exciting milestones within our
clinical and product development programs, as well as for our commercialization operations. This includes the announcement next
week of 12-month follow-up data for the MASTER trial in San Francisco at the Transcatheter Cardiovascular Therapeutics (TCT) Conference
A live webcast of the NYSE Opening Bell
Ceremony will be available online at:
A replay of the NYSE Opening Bell Ceremony
and photos from the event will be available at:
About InspireMD, Inc.
InspireMD seeks to utilize its proprietary
MGuard technology to make its products the industry standard for embolic protection stents and to provide a superior solution
to the key clinical issues of current stenting in patients with a high risk of distal embolization, no reflow and major adverse
InspireMD intends to pursue applications
of this technology in coronary, carotid and peripheral artery procedures. InspireMD's common stock is quoted on the NYSE MKT under
the ticker symbol NSPR.
MGuard EPS is CE Mark approved.
It is not approved for sale in the U.S. by the FDA at this time.
Todd Fromer / Garth Russell
KCSA Strategic Communications
Phone: 212-896-1215 / 212-896-1250
Lewis Goldberg / Samantha Wolf
KCSA Strategic Communications
Phone: 212-896-1216 / 212-896-1220
Last updated: Oct 23, 2013